期刊文献+

肝内胆管细胞癌的临床病理学观察 被引量:7

Clinicopathological study of intrahepatic bile duct cancers from 1982 to 2011
暂未订购
导出
摘要 常见肝内胆管恶性肿瘤有肝内胆管癌(ICC)、细胆管细胞癌(CLC)及混合细胞型肝癌(CHC)中的胆管癌成分。ICC是肝脏第二常见恶性肿瘤,根据我院手术切除的3.3万余例肝脏恶性肿瘤的病理资料统计,肝细胞癌(HCC)和ICC分别占85.6%和7.7%,ICC的发病呈逐年上升趋势,具有易转移复发的生物学特性;CLC少见,因起源于肝脏双向分化的前体细胞而具有侵袭性强的特点;CHC的病理检出率有增多趋势,预后较HCC和ICC更差。准确的病理分型对于临床诊治和预后评估具有实际意义。 Based on tumor histogenesis, intrahepatic bile duct cancers can be classified as intrahepatic cholangiocarcinoma (ICC), cholan-giocellular carcinoma (CLC) , or combined hepatocellular-cholangiocarcinoma (CHC). ICC is the second most common hepatic malignant tumor type, after hepatocellular carcinoma (HCC). Pathological analysis of more than 33 000 malignant liver tumors surgically resected from patients in our hospital between January 1982 and December 2011 revealed that HCC and ICC types accounted for 85.6% and 7.7%, respectively. In addition, elinicopathological analyses of these tumors and patient cases revealed an annual increase in incidence of ICC that was accompanied by similar positive trends in metastasis and recurrence. CLC cases were rare, but generally characterized as aggressive and originating from bipotential hepatic progenitor cells. For CHC tumors, there was an increasing trend for the pathological detection rates, but the prognosis of CHC cases remained worse than that for either HCC or ICC. The accumulated data of our institute's cases of intrahepatic bile duct cancers over the past 30 years indicate that pathological classification has important clinical implications for treatment and outcome.
作者 朱珍 丛文铭
出处 《临床肝胆病杂志》 CAS 2013年第1期42-44,共3页 Journal of Clinical Hepatology
关键词 胆管肿瘤 病理学 临床 bile duct neoplasms pathology, clinical
  • 相关文献

参考文献20

  • 1丛文铭,吴孟超.肝内胆管癌的微卫星不稳定性和杂合性缺失特点[J].中华肿瘤杂志,2002,24(2):141-141. 被引量:7
  • 2丛文铭,吴孟超.肝癌基因组不稳定性的研究现状与展望[J].第二军医大学学报,2002,23(1):5-8. 被引量:14
  • 3周福平,胡和平,艾建华,陆豪杰,王红阳,吴孟超.运用激光捕获显微切割对肝细胞癌与肝内胆管癌蛋白质组的分析[J].第二军医大学学报,2005,26(10):1111-1114. 被引量:4
  • 4Kobayashi M,Ikeda K,Saitoh S. Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis[J].Cancer,2000,(11):2471-2477.
  • 5俞文隆,张永杰,董辉,俞花,冼志红,吴孟超,丛文铭.肝门部胆管癌的病理生物学特点及其临床意义的研究[J].中华外科杂志,2009,47(15):1162-1166. 被引量:3
  • 6Varnholt H,Vauthey JN,Dal Cin P. Biliary adenofibroma:a rare neoplasm of bile duct origin with an indolent behavior[J].American Journal of Surgical Pathology,2003,(05):693-698.
  • 7Borbath I,Verbrugghe L,Lai R. Human equilibrative nucleoside transporter 1(hENT1)expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma[J].European Journal of Cancer,2012,(07):990-996.
  • 8Mitsuo S,Sugimoto J,Iwahashi S. CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma[J].Journal of Gastroenterology,2010,(08):896-902.
  • 9Higashi M,Yamada N,Yokoyama S. Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type[J].Pathobiology:Journal of Immunopathology,Molecular and Cellular Biology,2012,(02):101-106.
  • 10Min JK,Kim JM,Li SJ. L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma[J].Clinical Cancer Research,2010,(14):3571-3580.

二级参考文献28

  • 1张永杰,俞文隆,黄立嵩,史嵩,杨珏.联合肝叶切除及区域淋巴清扫治疗肝门部胆管癌的初步观察[J].外科理论与实践,2005,10(4):323-327. 被引量:14
  • 2周宁新,黄志强,张文智,黄晓强,王敬,刘荣,纪文斌,肖梅,孟翔飞.402例肝门部胆管癌临床分型、手术方式与远期疗效的综合分析[J].中华外科杂志,2006,44(23):1599-1603. 被引量:95
  • 3Cong WM,Bakker A,Swalsky PA,et al.Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma:a molecular genetic and clinicopathological study.J Cancer Res Clin Oncol,2001,127:187-192.
  • 4Ito F,Agni R,Rettammel RJ,et al.Resection of hilar cholangiocarcinoma:concomitant liver resection decreases hepatic recurrence.Ann Surg,2008,248:273-279.
  • 5Thelen A,Scholz A,Bcnckert C,et al.Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinnma.J Gastroenterol,2008,43:959-966.
  • 6Mobius C,Demuth C,Aigner T,et al.Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocaroinoma.Eur J Surg Oncol,2007,33:1025-1029.
  • 7Esposito I,Schirmacher P.Pathological aspects of cholangiocarcinoma.HPB (Oxford),2008,10:83-86.
  • 8Thelen A,Scholz A,Benckert C,et al.Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma.Ann Surg Oncol,2008,15:791-799.
  • 9Hamilton SR,Aaltonen LA.World health organization classification of tumoars:pathology and genetics of tumours of the digestive system.Lyon:IARC Press,2000:158-198.
  • 10Zen Y,Sasaki M,Fujii T,et al.Different expression patterns of mucin core proteins and cytokeratins during intrahcpatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intreductal papillary neoplasm of the bile duct-an immunohistochemical study of 110 cases of hepatolithiasis.J Hepatol,2006,44:350-358.

共引文献23

同被引文献91

  • 1张德东,于晓玲,梁萍,于明安,程志刚,韩志宇,戚彩,于杰.经皮微波消融治疗肝内胆管细胞癌的疗效分析[J].中华医学超声杂志(电子版),2011,8(11):2314-2319. 被引量:5
  • 2Yasuni Nakanuma,Yasunori Sato,Kenichi Harada,Mokoto Sasaski,Hiroko Ikeda.Pathological classification of intrahepatic cholangiocarcinoma based on a new concept[J].World Journal of Hepatology,2010,2(12):419-427. 被引量:42
  • 3王炳生,秦净,邓杰,张柏和,韩天权,沈铭昌,Asif Rashid,Ann W Hsing,高玉堂.上海市胆道癌诊治情况的调查和分析[J].中华外科杂志,2005,43(7):455-459. 被引量:15
  • 4徐泱,樊嘉,周俭,邱双健,吴志全,余耀,黄晓武,汤钊猷,王玉琦.12例胆管细胞癌患者肝移植的预后分析[J].中华器官移植杂志,2007,28(11):662-665. 被引量:4
  • 5Njei B.Intrahepatic cholangiacarcinoma:are we doing the right thing?[J].Gastrointerst Cancer Res,2014,7(1):1-3.
  • 6Konstadoulakis MM,Roayaie S,Gomatos IP,et al.Fifteen-year,single-center experience with the surgical management of intrahepatic cholangiocarcinoma:operative results and long-term outcome[J].Surgery,2008,143(3):366-374.
  • 7Shimada M,Sugimoto K,Iwahashi S,et al.CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma[J].J Gastroenterol,2010,45 (8):896-902.
  • 8Edge SB,Compton CC.The American Joint Committee on Cancer:the 7th edition of the AJCC cancer staging manual and the future of TNM[J].AnnSurgOncol,2010,17(6):1471-1474.
  • 9Bridgewater J,Galle PR,Khan SA,et al.Guidelines for the diagnosis and management of intrahepatic cholangiacarcinoma[J].J Hepatol,2014,60(6):1268-1289.
  • 10Brown KM,Parmar AD,Geller DA.Intrahepatic cholangiacarcinoma[J].Surg Oncol Clin N Am,2014,23(2):231-246.

引证文献7

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部